Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Beam Therapeutics (BEAM) Depreciation & Amortization (IS) (2024 - 2025)

Beam Therapeutics (BEAM) has disclosed Depreciation & Amortization (IS) for 2 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) rose 4.13% to $5.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.3 million, a 1.68% increase, with the full-year FY2025 number at $22.3 million, up 1.68% from a year prior.
  • Depreciation & Amortization (IS) was $5.7 million for Q4 2025 at Beam Therapeutics, up from $5.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $5.7 million in Q4 2025 to a low of $5.4 million in Q1 2024.